Trial of Accelerated Adjuvant Chemotherapy With Capecitabine in Early Breast Cancer.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2017
At a glance
- Drugs Capecitabine (Primary) ; Epirubicin (Primary) ; Cyclophosphamide; Cyclophosphamide; Fluorouracil; Methotrexate; Pegfilgrastim
- Indications Early breast cancer; Male breast cancer
- Focus Therapeutic Use
- Acronyms TACT2
- 19 Mar 2014 Efficacy results on capecitabine vs CMF presented at the 9th European Breast Cancer Conference.
- 19 Mar 2014 Accruel to date is 97% according to UK Clinical Research Network
- 08 Dec 2012 Results presented at the 35th Annual San Antonio Breast Cancer Symposium.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History